About
Brad Morie oversees the licensing of RCT's biotechnology programs, including Pichia Classic, Pichia GlycoSwitch, ClearColi and other protein expression platforms. He previously held business development and licensing roles at Ajinomoto Bio-Pharma Services, Catalent, Lonza, BIOCRATES and Los Alamos National Laboratory.
Contact· self-published, not guessed
Invests in
Biotech
Colleagues at Research Corporation Technologies
Avi Roop
Managing Director at Research Corporation Technologies
Chad W. Souvignier
Vice President at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
David A. Wiersma
Senior Associate at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies
Maggie Zhou
Associate Controller at Research Corporation Technologies
Frequently asked questions
- Who is Brad Morie?
- Brad Morie oversees the licensing of RCT's biotechnology programs, including Pichia Classic, Pichia GlycoSwitch, ClearColi and other protein expression platforms. He previously held business development and licensing roles at Ajinomoto Bio-Pharma Services, Catalent, Lonza, BIOCRATES and Los Alamos National Laboratory.
- Where does Brad Morie work?
- Brad Morie is Senior Director, Biotechnologies at Research Corporation Technologies.
- What does Brad Morie invest in?
- Brad Morie invests in Biotech.